LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency
2023-06-12
(Press-News.org)
“[...] we demonstrated the new acylfulvene compound LP-284 has anti-tumor activity including nanomolar potency in fifteen in vitro NHL cell lines and in vivo preclinical NHL models.”
BUFFALO, NY- June 12, 2023 – A new research paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, “LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair.”
Despite advances in therapies treating non-Hodgkin’s lymphoma (NHL), 20~40% of patients experience relapsed or refractory disease. While solid tumors with homologous recombination deficiencies have been successfully targeted with synthetic lethal agents such as poly-ADP ribose polymerase (PARP) inhibitors, such synthetic lethality strategy has not yet been approved to treat patients with NHL.
In this new study, researchers Jianli Zhou, Drew Sturtevant, Cassie Love, Aditya Kulkarni, Neha Biyani, Umesh Kathad, Elizabeth Thacker, Sandeep Dave, and Kishor Bhatia from Lantern Pharma Inc., Duke University and Data Driven Bioscience investigated the mechanism of action (MoA) and therapeutic potential of a new-generation acylfulvene compound, LP-284, in both in vitro and in vivo NHL models.
“Here, we aimed to characterize LP-284’s antitumor efficacy in NHL models and further elucidate its mechanisms of action.”
One of LP-284’s MoA includes inducing the repair of double-strand DNA break (DSB). The researchers found that LP-284 exerts nanomolar potency in a panel of hematological cancer cell lines including fifteen NHL cell lines. In vivo, LP-284 treatment prolongs the survival of mantle cell lymphoma (MCL) cell line JeKo-1 derived xenograft mice by two-fold and shows increased efficacy over bortezomib and ibrutinib. In addition, LP-284 is capable of inhibiting tumor growth of JeKo-1 xenografts that are refractory to bortezomib or ibrutinib. They further showed that LP-284 is particularly lethal in cells with deficient DNA damage response and repair, a targetable vulnerability in NHL.
“In conclusion, our study has demonstrated LP-284 as a novel and potent acylfulvene drug that can suppress tumor growth in NHL models and cells with HR or TC-NER deficiency.”
Read the full paper: DOI: https://doi.org/10.18632/oncotarget.28454
Correspondence to: Jianli Zhou - Email: jianli@lanternpharma.com
Keywords: non-Hodgkin's lymphoma, DNA damage, homologous recombination repair, transcription-coupled nucleotide excision repair, ATM
About Oncotarget: Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:
Twitter
Facebook
YouTube
Instagram
LinkedIn
Pinterest
LabTube
Soundcloud
Sign up for free Altmetric alerts about this article: https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28454
Click here to subscribe to Oncotarget publication updates.
For media inquiries, please contact: media@impactjournals.com.
Oncotarget Journal Office
6666 East Quaker Str., Suite 1A
Orchard Park, NY 14127
Phone: 1-800-922-0957 (option 2)
###
END
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
2023-06-12
Three scientists with exceptional promise and novel approaches to fighting cancer have been named the 2023 recipients of the Damon Runyon Physician-Scientist Training Award. The awardees were selected through a highly competitive and rigorous process by a scientific committee comprised of leading cancer researchers who are themselves physician-scientists.
Physician-scientists are uniquely positioned to translate scientific discoveries into therapies that improve and prolong the lives of their patients. However, ...
2023-06-12
As the world struggles for sustainability in the face of climate change, wildfire smoke becomes a lesson in how people can become victims far from the root of a problem and far from their control.
In this month’s open access National Science Review, Jianguo “Jack” Liu, MSU Rachel Carson Chair in Sustainability, makes a case for the world to shake off the constraints of traditional governance, which tends to address issues in one place without considering how people or ecologies near and far might be impacted.
Justice at a global scale can be threatened when natural events or human decisions in one part of the world to protect, reroute, ...
2023-06-12
New findings from a project led by researchers at Dartmouth’s Geisel School of Medicine in collaboration with the National Cancer Institute (NCI) and published in the journal JAMA Network Open, show the dramatic impact that smoking status has on mortality and more accurately predict the risk of dying from cancer and other diseases.
“Historically, mortality risk has often been presented by age, sex, and race but it rarely has accounted for smoking status—a major risk factor for many causes of death,” says lead author Steven Woloshin, MD, MS, a professor of ...
2023-06-12
(MEMPHIS, Tenn., June 12, 2023) St. Jude Children’s Research Hospital today announced that Victor J. Torres, Ph.D., an internationally renowned microbiologist and immunologist has been selected as the inaugural chair of a new Department of Host-Microbe Interactions. This department will establish a world-leading effort focused on exploring the fundamental biology of the interaction of infectious agendas with the human host. The discoveries made through this new effort will advance our ability to more effectively treat, as well as prevent infectious diseases
“Infectious diseases remain one of the leading causes of death globally for children under the age of five,” ...
2023-06-12
UNIVERSITY PARK, Pa. — Cloud-based computing directly contributes to business innovation, but rural businesses lacking sufficient broadband capacity to access cloud services are missing out on their innovation-boosting potential, according to a team of researchers from Penn State and the National Science Foundation. The findings can be used by policymakers and business-support organizations to foster greater opportunities for rural innovation.
“Innovation plays a critical role in keeping businesses competitive and viable, and in turn, healthy businesses are essential to vibrant rural economies. Therefore, we’re interested ...
2023-06-12
Of the 38 million people worldwide living with HIV, approximately 700,000 are newly infected men, primarily via sexual transmission. Sexually transmitted HIV infections in exclusively heterosexual men are acquired through the penis. In addition, semen which is produced in the male genital tract (MGT) has been recognized as the primary vector for vaginal and rectal HIV transmission. Notably, the risk of sexual HIV transmission increases with the presence of a concurrent sexually transmitted infection.
For the majority of patients, antiretroviral therapy (ART) rapidly decreases the viral load in blood and semen, ...
2023-06-12
In a recently published manuscript, Howard Colman, MD, PhD, Jon M. Huntsman Presidential Professor of Neuro-Oncology and co-leader of the Neurologic Cancers Disease Center and the Experimental Therapeutics CCSG program at Huntsman Cancer Institute, identified a potential breakthrough in glioblastoma treatment.
Glioblastoma, or GBM, is an aggressive type of brain cancer. According to Colman, this is the most common type of cancerous brain tumor in adults. Standard treatments include radiation and chemotherapy. Unfortunately, typical GBM tumors are often resistant ...
2023-06-12
CHICAGO—The American Medical Association (AMA) House of Delegates today passed the Endocrine Society’s resolution to protect access to evidence-based gender-affirming care for transgender and gender-diverse individuals.
As political attacks on gender-affirming care escalate, it is the responsibility of the medical community to speak out in support of evidence-based care. Medical decisions should be made by patients, their relatives and health care providers, not politicians.
In the resolution, the AMA committed to opposing any criminal and legal penalties against patients seeking ...
2023-06-12
Abstract: https://www.acpjournals.org/doi/10.7326/M23-0540
URL goes live when the embargo lifts
An analysis of medical crowdfunding campaigns reveals the types of expenses that patients with diabetes may struggle to afford. The data showed that even insured patients with diabetes used GoFundMe to offset the excess costs of treatment beyond insulin, such as uncovered co-pays, indirect care, and alert dogs. The findings are published in Annals of Internal Medicine.
More than 40% of patients with diabetes in the United States have trouble ...
2023-06-12
Studies show that consumers believe people who work hard for their money have higher incomes, are more financially literate and are more comfortable taking on prudent financial risk.
Similarly, national survey data used by policymakers to assess the relationship between effortful earning and financial risk-taking also shows a positive correlation between the two.
While, at the population level this may be true, new research from the University of Notre Dame shows that the harder an individual ...
LAST 30 PRESS RELEASES:
[Press-News.org] LP-284 targets non-Hodgkin's lymphoma and DNA damage repair deficiency
